tirzepatide obstructive sleep apnea fda approval 2024 ๐จ BREAKING: A New Era for Treatment! ๐จ, For the first time ever, the has approved Zepbound (tirzepatide) to treat sleep apnea (OSA) in adults with obesity!, ๐ Clinical F.D.A. Approves Weight-Loss Drug to
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Sep 23 - Sep 28


























